Springer Nature
Browse
12883_2016_606_MOESM7_ESM.docx (57.85 kB)

Additional file 7: of A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer’s disease and Parkinson’s disease

Download (57.85 kB)
journal contribution
posted on 2016-06-16, 05:00 authored by David McGhee, Craig Ritchie, John Zajicek, Carl Counsell
Methods used to differentiate symptomatic from disease-modifying drug effects in all RCTs in AD. (DOCX 57 kb)

Funding

National Institute for Health Research

History

Usage metrics

    BMC Neurology

    Categories

    Keywords

    Alzheimer’s diseaseParkinson’s diseaseDisease progressionBiomarkersClinical trialsNeuroprotective agents

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC